358 related articles for article (PubMed ID: 14759316)
21. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
Veen C; van den Hamer CJ; de Leeuw PW
J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
[TBL] [Abstract][Full Text] [Related]
22. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
[TBL] [Abstract][Full Text] [Related]
24. [Results of the treatment of Wilson's disease with zinc sulfate and d-penicillamine].
Szleper M; Rodo M; Piłkowska E; Członkowska A
Pol Tyg Lek; 1992 May 18-25; 47(20-21):456-8. PubMed ID: 1437767
[TBL] [Abstract][Full Text] [Related]
25. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
26. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
27. Serum transaminases in children with Wilson's disease.
Iorio R; D'Ambrosi M; Marcellini M; Barbera C; Maggiore G; Zancan L; Giacchino R; Vajro P; Marazzi MG; Francavilla R; Michielutti F; Resti M; Frediani T; Pastore M; Mazzarella G; Fusco G; Cirillo F; Vegnente A;
J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):331-6. PubMed ID: 15448420
[TBL] [Abstract][Full Text] [Related]
28. Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients.
Umeki S; Ohga R; Konishi Y; Yasuda T; Morimoto K; Terao A
Am J Med Sci; 1986 Nov; 292(5):289-92. PubMed ID: 3777013
[TBL] [Abstract][Full Text] [Related]
29. Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a Wilson disease patient with hepatic presentation, anxiety and SPECT abnormalities.
Leggio L; Ferrulli A; Mirijello A; Abenavoli L; Di Giuda D; Funiciello S; Rotoli M; Gasbarrini G; Addolorato G
Int J Immunopathol Pharmacol; 2007; 20(1):185-90. PubMed ID: 17346443
[TBL] [Abstract][Full Text] [Related]
30. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
Li T; Lin R; Du S; Qu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
[TBL] [Abstract][Full Text] [Related]
31. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
32. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
33. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
34. Zinc therapy as the initial treatment for Wilson's disease.
Hoogenraad TU; Van Hattum J
Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
[No Abstract] [Full Text] [Related]
35. Oral zinc sulphate for Wilson's disease.
Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
[TBL] [Abstract][Full Text] [Related]
36. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
37. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
38. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study.
Ranucci G; Di Dato F; Spagnuolo MI; Vajro P; Iorio R
Orphanet J Rare Dis; 2014 Mar; 9():41. PubMed ID: 24661374
[TBL] [Abstract][Full Text] [Related]
39. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Dastych M; Procházková D; Pokorný A; Zdrazil L
Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
